Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.47% 16.75 16.50 17.00 17.00 16.75 17.00 243,147 15:56:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.4 -0.9 - 20

SkinBioTherapeutics PLC Grant of Options

18/09/2020 4:48pm

UK Regulatory (RNS & others)


Skinbiotherapeutics (LSE:SBTX)
Historical Stock Chart


From Aug 2020 to Oct 2020

Click Here for more Skinbiotherapeutics Charts.

TIDMSBTX

RNS Number : 4915Z

SkinBioTherapeutics PLC

18 September 2020

18 September 2020

SkinBioTherapeutics plc

("SkinBioTherapeutics" or "the Company" or "the Group")

Grant of Options

SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, announces that the Company has granted a total of 1,809,695 options to subscribe for new ordinary shares in the Company under the SkinBioTherapeutics Share Option Program to Professor Catherine O'Neill, Chief Scientific Officer and Stuart Ashman, CEO both PDMRs of the Company on 3 March and 8 April 2020 respectively (the "Options"). Following an internal review of announcements it was noted that no notification had been made at the time of the relevant grants in accordance with article 19(3) of the Market Abuse Regulation and this announcement corrects this omission.

The Options for Professor O'Neill have vested with immediate effect, are exercisable at a price of 9.5p per share and will expire on 3 March 2030.

The Options for Mr Ashman can be exercised no earlier than 24 months from the date of grant and are subject to achieving performance milestones set by the Company's board which are aligned to growth in shareholder value and commercialisation of the Company's technology. The Options are exercisable at a price of 9p per share and will expire on 8 April 2030.

The following options have been granted to Directors and PDMRs:

 
  Director                Number of       Total number 
                        options granted    of options 
  Catherine O'Neill        512,334         4,404,416 
  Stuart John 
   Ashman                 1,297,361        5,189,444 
 
 
 SkinBioTherapeutics plc                         Tel: +44 (0) 161 
  Stuart J. Ashman, CEO                           468 2760 
  Doug Quinn, CFO 
 Cenkos Securities Plc (Nominated Adviser        Tel: +44 (0) 20 7397 
  & Broker)                                       8900 
  Giles Balleny, Max Gould (Corporate Finance) 
  Michael Johnson (Sales) 
 Instinctif Partners                             Tel: +44 (0) 20 7457 
  Melanie Toyne-Sewell / Phillip Marriage         2020 
  / Nathan Billis                                 SkinBio@instinctif.com 
 

T he below makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1       Details of the person discharging managerial responsibilities/person 
          closely associated 
        ---------------------------------------------------------------------------------------- 
 a.      Name                                     Professor Catherine O'Neill 
        ---------------------------------------  ----------------------------------------------- 
 2       Reason for notification                   Grant of share options 
        ---------------------------------------  ----------------------------------------------- 
 a.      Position/Status                          Chief Scientific Officer 
        ---------------------------------------  ----------------------------------------------- 
 b.      Initial notification/                    Initial notification 
          Amendment 
        ---------------------------------------  ----------------------------------------------- 
 3       Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
        ---------------------------------------------------------------------------------------- 
 a.      Name                                     SkinBioTherapeutics Plc 
        ---------------------------------------  ----------------------------------------------- 
 b.      LEI                                      213800YMQOCB23FX6I06 
        ---------------------------------------  ----------------------------------------------- 
 4       Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
        ---------------------------------------------------------------------------------------- 
 a.      Description of                           Share options for ordinary shares of 1p 
          the financial                            each 
          instrument, type 
          of instrument 
 
          Identification                           ISIN: GB00BF33H870 
          Code 
        ---------------------------------------  ----------------------------------------------- 
 b.      Nature of the                             Grant of share options 
          transaction 
        ---------------------------------------  ----------------------------------------------- 
 
 c.      Price(s) and volume(s)                    Price(s) per              Volume(s) 
                                                    share 
        ---------------------------------------   ------------------------ 
                                                   9.5p                      512,334 
                                                  ------------------------  ---------------- 
 
 d.      Aggregated information 
 
          - Aggregated Volume                       n/a 
 
          - Price 
        ---------------------------------------  ----------------------------------------------- 
 e.      Date of the transaction                  3(rd) March 2020 
        ---------------------------------------  ----------------------------------------------- 
 f.      Place of the transaction                 O ff market 
        ---------------------------------------  ----------------------------------------------- 
 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1       Details of the person discharging managerial responsibilities/person 
          closely associated 
        ---------------------------------------------------------------------------------------- 
 a.      Name                                     Stuart John Ashman 
        ---------------------------------------  ----------------------------------------------- 
 2       Reason for notification                   Grant of share options 
        ---------------------------------------  ----------------------------------------------- 
 a.      Position/Status                          Chief Executive Officer 
        ---------------------------------------  ----------------------------------------------- 
 b.      Initial notification/                    Initial notification 
          Amendment 
        ---------------------------------------  ----------------------------------------------- 
 3       Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
        ---------------------------------------------------------------------------------------- 
 a.      Name                                     SkinBioTherapeutics Plc 
        ---------------------------------------  ----------------------------------------------- 
 b.      LEI                                      213800YMQOCB23FX6I06 
        ---------------------------------------  ----------------------------------------------- 
 4       Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
        ---------------------------------------------------------------------------------------- 
 a.      Description of                           Share options for ordinary shares of 1p 
          the financial                            each 
          instrument, type 
          of instrument 
 
          Identification                           ISIN: GB00BF33H870 
          Code 
        ---------------------------------------  ----------------------------------------------- 
 b.      Nature of the                             Grant of share options 
          transaction 
        ---------------------------------------  ----------------------------------------------- 
 
 c.      Price(s) and volume(s)                    Price(s) per              Volume(s) 
                                                    share 
        ---------------------------------------   ------------------------ 
                                                   9.0p                      1,297,361 
                                                  ------------------------  ---------------- 
 
 d.      Aggregated information 
 
          - Aggregated Volume                       n/a 
 
          - Price 
        ---------------------------------------  ----------------------------------------------- 
 e.      Date of the transaction                   8(th) April 2020 
        ---------------------------------------  ----------------------------------------------- 
 f.      Place of the transaction                 O ff market 
        ---------------------------------------  ----------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBUGDCLSBDGGI

(END) Dow Jones Newswires

September 18, 2020 11:48 ET (15:48 GMT)

1 Year Skinbiotherapeutics Chart

1 Year Skinbiotherapeutics Chart

1 Month Skinbiotherapeutics Chart

1 Month Skinbiotherapeutics Chart
ADVFN Advertorial
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201027 04:49:45